Growth Metrics

SOPHiA GENETICS (SOPH) Total Debt (2020 - 2025)

SOPHiA GENETICS recorded quarterly Total Debt of $47.7 million in Q4 2025, up 260.6% quarter-over-quarter from $13.2 million in Q4 2024, and up 260.6% year-over-year from $13.2 million in Q4 2024.

SOPHiA GENETICS's Total Debt history runs 3 years deep, the most recent figure standing at $47.7 million for Q4 2025.

  • In Q4 2025, Total Debt rose 260.6% year-over-year to $47.7 million; the TTM figure through Dec 2025 stood at $47.7 million (up 260.6% YoY), while the FY2025 annual figure was $47.7 million, up 260.6% from the prior year.
  • Total Debt came in at $47.7 million for Q4 2025 at SOPHiA GENETICS, up from $13.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $47.7 million in Q4 2025 to a low of $13.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 2.50 Bn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 942.66 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 1.47 Bn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 SOPHiA GENETICS 24.12 Mn -46.17 Mn 14.69 Mn 47.73 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 47.73 Mn
Dec 31, 2024 13.24 Mn
Dec 31, 2020 3.33 Mn